SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-117764
Filing Date
2020-10-23
Accepted
2020-10-23 17:08:58
Documents
14
Period of Report
2020-10-23
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2034060-1_8k.htm   iXBRL 8-K 43738
2 EXHIBIT 3.1 tm2034060d1_ex3-1.htm EX-3.1 10795
3 EXHIBIT 3.2 tm2034060d1_ex3-2.htm EX-3.2 57985
  Complete submission text file 0001104659-20-117764.txt   309339

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA immu-20201023.xsd EX-101.SCH 3198
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20201023_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20201023_pre.xml EX-101.PRE 22718
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2034060-1_8k_htm.xml XML 3597
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

IRS No.: 611009366 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12104 | Film No.: 201258423
SIC: 2835 In Vitro & In Vivo Diagnostic Substances